Location History:
- Seattle, WA (US) (2020)
- Stanford, CA (US) (2020 - 2023)
Company Filing History:
7 out of 2,104 
7 out of 5,309 
Years Active: 2020-2025
Title: Jamie Spangler: Innovator in Interleukin Mimetics
Introduction
Jamie Spangler is a prominent inventor based in Stanford, California. She has made significant contributions to the field of biotechnology, particularly in the design of interleukin mimetics. With a total of seven patents to her name, her work has the potential to impact therapeutic approaches in immunology.
Latest Patents
Among her latest patents, Jamie has developed de novo designed polypeptides that bind to various interleukin receptors. These include polypeptides that interact with the IL-2 receptor β heterodimer (IL-2Rβ), IL-4 receptor α heterodimer (IL-4Rα), and IL-13 receptor α subunit (IL-13Rα). Additionally, she has designed polypeptides that bind to the IL-2 receptor βγ heterodimer (IL-2Rβγ), IL-4 receptor αγ heterodimer (IL-4Rαγ), and IL-13 receptor α subunit (IL-13Rα). Her patents also disclose methods for using and designing these innovative polypeptides.
Career Highlights
Jamie has worked at prestigious institutions, including the University of Washington and Leland Stanford Junior University. Her research has focused on advancing the understanding of interleukin interactions and their therapeutic applications.
Collaborations
Throughout her career, Jamie has collaborated with notable colleagues, including Daniel Adriano Silva Manzano and Shawn Yu. These collaborations have further enriched her research and contributed to her innovative work in the field.
Conclusion
Jamie Spangler is a trailblazer in the development of interleukin mimetics, with a strong patent portfolio that showcases her innovative designs. Her contributions to biotechnology are paving the way for new therapeutic strategies in immunology.